Novel slow-binding reversible acetylcholinesterase inhibitors based on uracil moieties for possible treatment of myasthenia gravis and protection from organophosphate poisoning-Reference-Cited by-同舟云学术

Novel slow-binding reversible acetylcholinesterase inhibitors based on uracil moieties for possible treatment of myasthenia gravis and protection from organophosphate poisoning

Published:2023-01 Issue: Volume:246 Page:114949
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Saifina Liliya F.,Abdalla Mohnad,Gubaidullina Liliya M.,Zueva Irina V.,Eltayb Wafa Ali,El-Arabey Amr Ahmed,Kharlamova Alexandra D.,Lenina Oksana A.,Semenov Vyacheslav E.^ORCID,Petrov Konstantin A.

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference24 articles.

1. Autoimmune mechanisms in myasthenia gravis;Cavalcante;Curr. Opin. Neurol.,2012

2. J. Verschuurenellen, E. Strijbosane, A. Vincen, Neuromuscular junction disorders, in Handb. Clin. Neurol., Ed.: S.J. Pittock and A. Vincent, Vol. 133 (3rd series), Autoimmune Neurology. pp. 447-466.

3. Autoregulation of acetylcholine release and micro-pharmacodynamic mechanisms at neuromuscular junction: selective acetylcholinesterase inhibitors for therapy of myasthenic syndromes;Petrov;Front. Pharmacol.,2018

4. Respiratory complications of organophosphorus nerve agent and insecticide poisoning. implications for respiratory and critical care;Hulse;Am. J. Respir. Crit.,2014

5. Usefulness of administration of non-organophosphate cholinesterase inhibitors before acute exposure to organophosphates: assessment using paraoxon;Petroianu;J. Appl. Toxicol.,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and Antiviral Activity of New Dimeric 1,2,3-Triazolyl Pyrimidine Nucleoside Analogues;Russian Journal of Organic Chemistry;2024-04